CancerLife's Quality of Life Clinical Trial with the John Wayne Cancer Institute: Study #2 is Live

Marlon Saria PhD and Quality of Life Specialist at John Wayne Cancer Institute

Marlon Saria PhD and Quality of Life Specialist at John Wayne Cancer Institute

Are you interested in the results of our study? Enter your email and we will add you to our private email list and contact you before the results become public:

Study # 1: Results from CancerLife's Original Validation Study with the John Wayne Cancer Institute

CancerLife and Quality of Life specialist, Marlon Saria, PhD, have completed a Quality of Life research study focused on cancer patients, caregivers and survivors. Study highlights included:

  1. 88% of participant users stated that CancerLife improved their quality of life

  2. 100% stated that CancerLife was easy-to use

  3. 5.8 Average Journal Updates/Per Week

  4. 3.7 Social Shares/Per Week

Study users loved CancerLife. They were engaging on the platform almost everyday!

The Quality of Life Clinical Trial: The Big Picture Goal

The clinical trial will provide deep insights into how social support, Patient Reported Outcome (PRO) symptom data collection and other factors can impact patient outcomes.

The study piggybacks on mounting research evidence (including prior research at Memorial Sloan Kettering) which indicates that patients' quality of life may improve (by up to 36%) when patients share their moods (and get social support from family, friends and fellow patients) and, most important, share their symptom data with care teams. 

The Quality of Life Study #2 - Expanded Use of CancerLife by Cancer Survivors and Patients. (Currently Recruiting Patients) 

Approximately 2000 participants ( survivors and patients) will be recruited to participate in the study. Participants will use the CancerLife App for social sharing purposes and to collect PRO symptom data. Participants will take a series Quality of Life surveys, which will be tracked and monitored over a five-month period. 

Additionally, IBM Watson AI technology will analyze social sharing data and conversations using its proprietary machine learning and natural language processing algorithms. IBM Watson will help uncover key insights into participants cancer journeys. 

CancerLife's Commitment to the World

Understanding the correlation and implications on how social sharing and PRO data affect patients quality of life has  breakthough potential as it may help doctors better understand how the next wave of cancer drugs will impact patients' quality of life.

CancerLife is deeply committed to helping patients, survivors and caregivers—around the world experience a better quality of life. With that said, CancerLife's goal is to become the world's first cancer care complementary digital therapeutic.

Recruitment Partners: Want to Join the Quality of Life Crusade?

CancerLife is teaming with several nonprofits and patient groups that want to come together to help improve quality of life for all patients and participate in this pioneering study. All partners will have access to this data which will be shared with the industry to help improve care for all. We are calling this group of cancer organizations:

The Cancer "Quality of Life" Research Collaborative 

If your non-profit is interested joining the crusade and participating, please contact CancerLife to learn more now.

hipaa logo.png

Your privacy is assured